Dianthus Therapeutics (DNTH) has released an update to notify the public and investors about a regulation fd disclosure.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
On January 22, 2024, the Company announced a Private Placement through a press release. The press release, included in the Current Report on Form 8-K, provides information that, while not considered filed under Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into the Company’s Securities Act filings, is disclosed per the reporting requirements.
For further insights into DNTH stock, check out TipRanks’ Stock Analysis page.